Welcome to the official InxMed website
About Us

About Us

>
About
All categories
ABOUT US

Overview

InxMed is a clinical-stage biotech company established in the end of 2018. The company dedicates on developing innovative therapies targeting stroma microenvironment and solid tumor resistance and metastasis, especially new drug development on anti PD-1/PD-L1 treatment drug resistance. InxMed committees to building an efficient engine for clinical translational science and proof of concept platform driven by in-depth understanding of disease biology and is committed to becoming a global leader in revolutionary cancer therapies.

 

History

2018

Company founded Tens of millions USD of A round raised Preliminary R&D pipeline established

Jan,2019

Opening of InxMed Shanghai & Beijing offices

Sep, 2019

IN10018 Received US FDA IND Approval

Oct, 2019

Achieved clinical collaboration with Roche for IN10018 co-development

Dec, 2019

IN10018 Phase I Clinical Trial in China approved

Jan,2020

Achieved clinical collaboration with Merck for IN10018 co-development

Vision

With in-depth knowledge of disease biology at the core of our innovation, InxMed is committed to becoming a global leader in revolutionary cancer therapies

Vision
Mission

Mission

To invent personalized medicines with a global impact based on our integrated translational R&D platform

Leadership Team

Zaiqi Wang M.D.,Ph.D.
Zaiqi Wang M.D.,Ph.D.
Chairman & Chief Executive Officer
Fei Cao
Fei Cao
Co-founder and Chief Operating Officer
James Mc Leod M.D.
James Mc Leod M.D.
Chief Medical Officer
USA
Anfeng Guo
Anfeng Guo
Chief Commercial Officer 
Xuebin Liu M.D.,Ph.D.
Xuebin Liu M.D.,Ph.D.
Chief Science Officer
Jie Ding Ph.D.
Jie Ding Ph.D.
Senior Vice President,Biometrics

Management Team

Shuang Xie M.D.,Ph.D.
Shuang Xie M.D.,Ph.D.
Executive Director,Clinical R&D
Rangrong Li
Rangrong Li
Senior Director,Clinical Operation
Yanan Liu M.D.,Ph.D.
Yanan Liu M.D.,Ph.D.
Senior Director,Portfolio Management
Baoyuan Zhang Ph.D.
Baoyuan Zhang Ph.D.
Senior Director,Translational Medicine
Shiqiang Lu Ph.D.
Shiqiang Lu Ph.D.
Senior Director,Antibody Discovery
Liyuan Liu Ph.D.
Liyuan Liu Ph.D.
Senior Director,CMC
Zhaobin Zeng
Zhaobin Zeng
Senior Director,Regulatory Affairs
Fengmin Xi
Fengmin Xi
Director,DMPK
Libo Gao
Libo Gao
Director,Pharmacovigilance
Yuqi Qin Ph.D.
Yuqi Qin Ph.D.
Senior Director,Business Development
Yi Huang Ph.D.
Yi Huang Ph.D.
Director,External Affairs & Alliance Management
Yi Ren
Yi Ren
Senior Director,Human Resources

Key Contacts

Corporate Communications

 

PR@inxmed.com

Business Development

 

BD@inxmed.com

InxMed (Nanjing) Co., Ltd.

ADD: 73 Tanmi Road Block D-2, Jiangbei New District, Nanjing

InxMed(Shanghai)Co., Ltd.

ADD: 515 Huanke Road, Greenland M-Town Tower 1, Room 602-603 Pudong

InxMed (Beijing) Co., Ltd.

ADD: Room 2308-2310 Room 2308-2310, Block A , Gemdale Plaza,Tower 8,No.91 Jianguo Road.,Chaoyang District,Beijing

InxMed (Austrilia) Co., Ltd. 

ADD: 1204, 227 ELIZABETH STREET, SYDNEY, NSW, 2000

 

Online Message

Contact Us
 InxMed

We invent personalized medicines with global impact, and turn innovation in China to life saving therapies for the world

QUICK LINKS

CONTACT US

Tel: +86 25-58251030
Email: office@inxmed.com
Office address: 73 Tanmi Road Block D-2, 3rd Floor Jiangbei New District, Nanjing

MESSAGE

Follow Us:

CopyRight © 2022 InxMed All Rights Reserved.

Powered by: 300.cn | SEO